GBI Biomanufacturing
Pleasanton, CA, USA
Program data pending ClinicalTrials.gov matching
—
Not Assessed
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (10)
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesBiologics, mAb, Recombinant Proteins, Bio-conjugates
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
—
Insufficient financial data. Score requires company profile or SEC filings.
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
—
Insufficient capacity data. Score requires company profile with manufacturing site information.
Recent Press10 articles
Broad modality coverage (4 modalities)
Recent News 10 articles
GBI Biomanufacturing Expands Capabilities with Automated Aseptic Fill-Finish for Drug Products - PR Newswire
GBI Biomanufacturing, Plantation - Florida Trend
GBI Biomanufacturing Announces Sven Lee as New Board Member - PR Newswire
miRecule and GBI Biomanufacturing Partner on Advancing Antibody-RNA Conjugate Therapies - Genetic Engineering and Biotechnology News
GBI Biomanufacturing Partners with NanoRetinal to Advance Vision-Restoring Therapy for Inherited Retinal Diseases - PR Newswire
GBI Secures Commercial Manufacturing Contract, Solidifying Leadership in Radiopharmaceutical Manufacturing - BioSpace
GBI Biomanufacturing Appoints New President Jesse McCool - Contract Pharma
GBI Biomanufacturing Announces the Appointment of Jesse McCool, Ph.D. as President - PR Newswire
GBI Biomanufacturing Grows Drug Product Services - Pharmaceutical Commerce
GBI: AI will change the CDMO landscape, but not without trained staff - BioProcess International
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in: